Accedi a banche dati online | Convegnodetail
Anteprima di stampa

3rd Treg Directed Therapies Summit

Evvnt Promotion / evvnt
18.05.2021 - 20.05.2021  Online
Time: 09:00 - 17:30
Temi della conferenza
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.

Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics and more.

Informazioni ed Iscrizioni:
Mr. Treg Directed Therapies Summit Team
Medicina General
Quote del Congresso
Drug Developers (Earlybird rates and workshops available): USD 2099.0, Academic (Earlybird rates and workshops available): USD 1899.0, Service Providers (Earlybird rates and workshops available): USD 2599.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

newTreeSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienCenter of ExcellenceÖsterreichisches Rotes KreuzHilfswerk AustriaAMREF - African Medical and Research FoundationEuropean Health Forum Gastein